We have used adenovirus-mediated gene transfer in apoE -/-mice to elucidate the molecular etiology of a dominant form of type III hyperlipoproteinemia caused by the R142C substitution in apoE4.
INTRODUCTION
Apolipoprotein E (apoE) is a very important protein of the lipoprotein transport system. It is required for the clearance of lipoprotein remnants from the circulation and is essential for atheroprotection [1] [2] [3] .
Lipoprotein-bound apoE is the ligand for the LDL receptor as well as other receptors in vitro [4] [5] [6] . In vivo and in vitro studies have shown that mutations in apoE that diminish binding of apoE-containing lipoproteins to the LDL receptor are associated with high plasma cholesterol levels and cause premature atherosclerosis in humans and experimental animals [1] [2] [3] 7, 8] . Most recently we have shown that apoE is involved in the biogenesis of distinct apoE-containing HDL species with the participation of ABCA1 transporter and lecithin cholesterol acyltransferase (LCAT) [9] .
Certain apoE phenotypes and genotypes are associated with recessive or dominant forms of type III hyperlipoproteinemia (type III HLP). The recessive form of type III HLP is encountered in subjects with the E2/2 phenotype which results from the substitution of Cys for Arg-158 [10] . This mutation combined with other genetic or environmental factors affects the catabolism of apoE-containing lipoproteins and results in the accumulation in plasma of remnants of lipoprotein catabolism [7, 11] . A variety of rare mutations in the 136 to 147 region of apoE are associated with a dominant mode of inheritance of type III HLP which is expressed at an early age [7, 8, 12, 13] . The degree of penetrance of the disease varies depending on the mutation [7] .
In the present study we have investigated the molecular etiology of a dominant form of type III HLP that is caused by the R142C substitution in apoE4.
by guest, on October 30, 2017 www.jlr.org Downloaded from eluted with PBS. A total of 25 fractions of 50 ml volume each were collected for further analysis.
Triglycerides and cholesterol of plasma and the FPLC fractions were determined spectrophotometrically at 540 nm and 490 nm respectively, as described previously [16] using the Serum Triglyceride Kit (Sigma) and Thermo Infinity Cholesterol Reagent (Thermo Fisher), according to the manufacturer's instructions. Plasma apoE concentrations were determined by sandwich ELISA using apoE standards supplied by Wako Chemicals (Richmond, VA) [16] .
Statistical analysis. Data are presented as the mean ± standard deviation. Statistically significant differences between two groups of mice were determined using Student's t test with unequal variance.
Density gradient ultracentrifugation and electron microscopy (EM) analysis.
To assess the ability of WT and truncated apoE forms to associate with different lipoproteins, an aliquot of 0.3 ml of plasma was fractionated by KBr density gradient ultracentrifugation. Ten fractions were collected and analyzed by SDS-PAGE as described previously [18, 19] . Aliquots of fractions [6] [7] [8] obtained by density gradient ultracentrifugation that contain most of the apoE were analyzed by EM. The photomicrographs were taken at x75,000 magnification and enlarged three times as described previously [20] .
Non-denaturing two-dimensional electrophoresis. The distribution of HDL subfractions in plasma was analyzed by two-dimensional gel electrophoresis as described [19, 21] . ApoE was detected by probing the membrane with a goat polyclonal anti-human apoE antibody (Meridian Biosciences K74190G; Saco, ME).
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RESULTS

ApoE4[R142C] induces dyslipidemia characterized by high plasma cholesterol triglyceride
and apoE levels. To elucidate how the R142C substitution in human apoE4 induces dyslipidemia, we have employed adenovirus-mediated gene transfer of the full-length or the truncated forms of apoE4[R142C]-202 or the control WT apoE4 in apoE -/-mice. The experiments with the truncated apoE-202 forms were designed to assess the contribution of the C-terminal domain of the mutant protein in the induction of dyslipidemia. We have found that infection of apoE -/-mice with a low dose (5x10 8 pfu) of an adenovirus expressing apoE4 [R142C] increased plasma cholesterol over a four day period and induced severe hypertriglyceridemia ( Figure 1A ,B). The increase in triglyceride levels, correlated with parallel increases in plasma apoE levels ( Figure 1C ). In contrast, infection of apoE -/-mice with a similar dose (5x10 8 pfu) of adenovirus expressing wild-type apoE4 cleared cholesterol, did not affect plasma triglycerides levels and caused only small increase in plasma apoE levels ( Figure 1A -C). Real-time PCR analysis showed that the hepatic apoE4 and apoE4[R142C] mRNA four days post-infection were not statistically different ( Figure 1D ).
ApoE4[R142C] mediated dyslipidemia affects the HDL cholesterol esterification. FPLC
analysis of plasma from apoE -/-mice infected with 5x10 8 pfu of adenoviruses expressing wildtype apoE4 showed that over 85% of the cholesterol was found in HDL-sized particles and was mostly esterified ( Figure 1E ). In contrast, when apoE -/-mice were infected with 5x10 8 pfu of adenoviruses expressing apoE4[R142C], the great majority of cholesterol (over 90%) was distributed in the VLDL/IDL region and a small amount of cholesterol was found in HDL, and was unesterified ( Figure 1F ).
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Distribution of apoE to different lipoprotein fractions following density gradient ultracentrifugation and analysis of HDL fraction by electron microscopy. To assess the distribution of apoE and other apolipoproteins within different lipoprotein fractions, plasma obtained four days post-infection with adenoviruses expressing the wild-type or the mutant apoE4 forms were fractionated by density gradient ultracentrifugation, and the fractions were analyzed by SDS-PAGE. When the mice were infected with a low dose of apoE4-expressing adenovirus (5x10 8 pfu), most of the apoE was found in the HDL3 region. This distribution is consistent with the formation of apoE containing HDL as previously described [9] (Figure 2A ).
However, when the mice were infected with 5x10 8 pfu of adenovirus expressing apoE4[R142C] in addition to the apoE floating in the HDL3 region there was a dramatic increase of apoE in the VLDL/IDL/LDL region as well as a shift of apoE towards the HDL2 region ( Figure 2B ). Overall, there was a 7.5-fold increase of the mutant as compared to the WT apoE4 in plasma. Figure 2A ,B also indicates that as the human apoE levels increase, the mouse apoA-I levels decrease.
Electron microscopy of fractions 6 and 7 of Figure 2A ,B, that correspond to the HDL3 region,
showed that apoE -/-mice infected with a low dose (5x10 8 pfu) of apoE4 expressing adenovirus formed spherical HDL ( Figure 2C ), whereas mice infected with a low dose (5x10 8 pfu) of apoE4[R142C]-expressing adenovirus formed a mixture of spherical and discoidal HDL particles ( Figure 2D ). This is consistent with the CE/TC ratios of the HDL peak observed in Figure 1E ,F.
The combined data of Figure 1A -F and Figure 2A- Figure 1A As shown in Figure 5A ,B, treatment of apoE -/-mice with 7x10 8 
Contribution of the C-terminal domain of apoE4[R142C] in the induction of dyslipidemia.
The phenotype generated by the apoE4[R142C] mutation can be attributed exclusively to a defective recognition of the receptor-binding domain of apoE by the LDL receptor in vivo.
Alternatively, additional factors brought about by interactions of the N-and C-terminal domains of the mutant apoE might contribute to the aberrant phenotype. To address this question, we Plasma apoE levels were significantly lower in mice expressing the WT as compared to the mutant truncated apoE form ( Figure 7D ). Real-time PCR analysis of human apoE mRNA showed that the hepatic human apoE mRNA levels of mice infected with 2x10 9 pfu of adenoviruses expressing apoE4[R142C]-202 or apoE4-202 were comparable ( Figure 7C ). In addition, the hepatic apoE mRNA levels of mice infected with 3.5x10 9 pfu of adenoviruses expressing apoE4[R142C]-202 were lower than in mice infected with the same dose of adenoviruses expressing apoE4-202 ( Figure 7C ).
Important differences in the plasma FPLC profiles were observed when mice were infected with 3.5x10 9 pfu of adenovirus expressing either the wild-type or the mutant truncated apoE When the apoE -/-mice were infected with 2x10 9 pfu of adenovirus expressing the wild-type or the mutant form of apoE4-202 the residual cholesterol on day 4 was distributed in all lipoprotein classes, and the HDL cholesterol was mostly esterified (CE/TC 0.63 to 0.70) and the VLDL/IDL/LDL cholesterol was mostly unesterified (Supplementary Fig. 2A,B) . In contrast, the cholesterol of all lipoprotein classes in non-infected apoE -/-mice was mostly esterified (CE/TC ratio 0.72 to 0.87) ( Supplementary Fig. 2C ).
Density gradient ultracentrifugation of plasma followed by SDS-PAGE analysis of the resulting fractions showed that when mice were infected with 3.5x10 9 pfu of adenovirus expressing apoE4[R142C]-202 or apoE4-202, the major portion of apoE was distributed in the HDL2 region and to a lesser extent in the HDL3 region, whereas the endogenous mouse apoA-I was found predominantly in the HDL3 region and the lipoprotein-free fraction ( Figure 8A ,B).
Electron microscopy of the HDL fractions 5+6 (of Figure 8A ,B) that are enriched in apoE,
showed the presence of a mixture of discoidal and spherical HDL particles ( Figure 8C,D) .
Based on the apoprotein composition of the HDL fractions analyzed by EM, the particles originating from apoE4-202 contain both apoA-I and apoE ( Figure 8A ) and those originating from the apoE4[R142C]-202 mutant contain predominantly apoE ( Figure 8B ). Taken together, the findings illustrated in Figures 7 and 8 [7, 12] .
The importance of the 136-152 region of apoE for binding to the LDL receptor was assessed by in vitro mutagenesis [8, 13, 22] . It has been recognized that the binding affinity of these apoE mutants for the receptor observed in vitro did not always correlate with the severity of the dyslipidemia observed in vivo. Thus it was suggested that the occurrence of the disease can be influenced by other secondary factors [7, 8, 13, [22] [23] [24] . These factors may be related to the apoE phenotype which affects the distribution of apoE to different lipoprotein classes [25, 26] or interaction of apoE with heparan sulfate proteoglycans [27] .
Heterozygous patients with a dominant form of type III HLP carrying the e3 allele and a mutant allele were described in 1983 [28] . The product of the mutant allele predominated in the plasma of the affected subjects by 3:1 as compared to the product of the normal e3 allele [13] .
Sequence analysis identified an R142C substitution in the e4 allele (Arg112 Cys142 Arg158) [29] . DMPC proteoliposomes containing the R142C variant expressed in bacteria had reduced mutant have been generated and studied. These lines expressed the mutant apoE allele as well as their endogenous mouse apoE gene [30] [31] [32] . Some of the mouse lines produced a phenotype characterized by mild hypercholesterolemia, hypertriglyceridemia, and very high levels of plasma apoE [30] . The β-VLDL obtained from these mice was cleared at a significantly slower rate than normal mouse VLDL [30] .
Lipid and lipoprotein phenotype of E -/-mice expressing the apoE4[R142C] mutant. Here we have studied the molecular etiology of the dominant dyslipidemia caused by the apoE4[R142C] mutation using adenovirus mediated gene transfer in apoE -/-mice. The advantage of the adenovirus system is that when the mutant protein is expressed in apoE -/-mice, it creates within a few days the phenotype expected of subjects with homozygous defect in e4. Human subjects or experimental animals homozygous for the R142C mutation have not been studied previously.
Our studies provide novel information on the lipid and lipoprotein abnormalities that are associated with the R142C substitution in apoE4. The phenotype generated by expression of the apoE4[R142C] mutant in apoE -/-mice is much more severe than in transgenic mice which also express the endogenous apoE gene [30] . The observed phenotype is characterized by severe hypercholesterolemia and hypertriglyceridemia, reduced CE/TC ratio in different lipoprotein fractions formation of discoidal apoE-containing HDL very high plasma apoE levels and accumulation of apoE in the VLDL/IDL/LDL region. Abnormal lipid and lipoprotein phenotypes have been observed in mice as a result of overexpression of the endogenous mouse apoE [33] .
Thus the observed dyslipidemia in this study cannot be attributed to abnormal interactions of the human apoE with the mouse apolipoproteins. The phenotype generated by apoE4[R142C] is dominant and persists when the mutant and the WT apoE are coexpressed in apoE -/-mice. 
Induction of dyslipidemia requires the C-terminal region of apoE4[R142C]. ApoE contains
an N-terminal and a C-terminal domain which unfold independently [42, 43] . The x-ray crystallography of lipid-free apoE isoforms showed that apoE4 is more compact than apoE3 due to differences in domain interactions [44] [45] [46] . It has been proposed that these interactions may be at least partially responsible for the preferential association of apoE4 with VLDL [25, [45] [46] [47] as well as the contribution of apoE4 in Alzheimer's disease [48] .
We have shown recently that defective recognition of apoE-containing lipoproteins, either due to mutations in apoE or deficiency in the LDL receptor, may increase the sensitivity and severity of hypertriglyceridemia [49] . The same studies also showed that the LDL receptor alone can account for the clearance of apoE-containing lipoprotein remnants in mice, and that the contribution of the other members of the LDL-receptor family and heparan sulfate proteoglycans (HSPGs) may be limited [49] . 
